Description
The synthesizer proposed CRISPR-mediated transient upregulation of transcytosis machinery, but the debate did not address how to control duration, reversibility, or off-target effects. These parameters are essential for therapeutic safety and efficacy.
Source: Debate session sess_SDA-2026-04-01-gap-008 (Analysis: SDA-2026-04-01-gap-008)